Search filters

List of works by Mia Wadelius

5alpha-reductase 2 polymorphisms as risk factors in prostate cancer

scientific article published in June 2002

A Bayesian decision support tool for efficient dose individualization of warfarin in adults and children

scientific article published on 7 February 2015

A Genome-Wide Association Study of Bisphosphonate-Associated Atypical Femoral Fracture

scientific article published on 20 April 2019

A PK-PD model for predicting the impact of age, CYP2C9, and VKORC1 genotype on individualization of warfarin therapy

scientific article published on 14 February 2007

A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose

scientific article

A pharmacometric model describing the relationship between warfarin dose and INR response with respect to variations in CYP2C9, VKORC1, and age.

scientific article published on 21 April 2010

A proposal for an individualized pharmacogenetics-based warfarin initiation dose regimen for patients commencing anticoagulation therapy

scientific article published on 28 September 2011

A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon

scientific article

A randomized trial of genotype-guided dosing of warfarin

scientific article published on 19 November 2013

A simplified assay for the arylamine N-acetyltransferase 2 polymorphism validated by phenotyping with isoniazid ⬇️

scientific article published on September 1, 1997

A systematic review of cost-effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivatives

scientific article published on July 2010

Apolipoprotein E (APOE) and warfarin dosing in an Italian population

scientific article published on 26 August 2005

Application of a pharmacogenetic-based warfarin dosing algorithm derived from British patients to predict dose in Swedish patients

scientific article published on 14 April 2008

Assessment of 105 Patients with Angiotensin Converting Enzyme-Inhibitor Induced Angioedema

scientific article published on 14 February 2017

Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study

scientific article published on 30 December 2016

Association of the GGCX (CAA)16/17 repeat polymorphism with higher warfarin dose requirements in African Americans

scientific article published on February 2012

Association of warfarin dose with genes involved in its action and metabolism

scientific article published on 18 October 2006

CKM Glu83Gly Is Associated With Blunted Creatine Kinase Variation, but Not With Myalgia

scientific article published on August 2017

CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysis

scientific article published on 01 November 2019

CYP2D6 genotypes and depressive symptoms during late pregnancy and postpartum

scientific article published in January 2004

Can mutations in ELA2, neutrophil elastase expression or differential cell toxicity explain sulphasalazine-induced agranulocytosis?

scientific article

Characteristics associated with drug-induced liver injury from interferon beta in multiple sclerosis patients

scientific article published on 18 August 2014

Characterizing variability in warfarin dose requirements in children using modelling and simulation

scientific article

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update

scientific article published on 15 February 2017

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing

scientific article

Clinical factors predicting drug-induced liver injury due to flucloxacillin

scientific article published on 21 November 2018

Cohort-specific imputation of gene expression improves prediction of warfarin dose for African Americans

scientific article published on 24 November 2017

Common VKORC1 and GGCX polymorphisms associated with warfarin dose

scientific article

Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis

scientific article published on 16 July 2018

Comparison of Clinical Factors Between Patients With Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema and Cough

scientific article published on 25 November 2016

Corrigendum to "Assessment of 105 Patients with Angiotensin Converting Enzyme-Inhibitor Induced Angioedema".

scientific article

Cost-effectiveness of pharmacogenetic-guided dosing of phenprocoumon in atrial fibrillation

scientific article published in June 2013

Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden

scientific article

Cost-effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs

scientific article published on September 2012

Cytochrome p450 genotyping by multiplexed real-time dna sequencing with pyrosequencing technology

scientific article

Erratum to: Warfarin dose prediction in children using pharmacometric bridging – comparison with published pharmacogenetic dosing algorithms.

scientific article published on 10 August 2013

Functional role of P-glycoprotein in the human blood-placental barrier

scientific article published in August 2005

Fusidic Acid: A Neglected Risk Factor for Statin-Associated Myopathy

Gamma-glutamyl carboxylase (GGCX) microsatellite and warfarin dosing

scientific article published in November 2005

Genetic determinants of dabigatran plasma levels and their relation to bleeding

scientific article

Genetic determinants of warfarin maintenance dose and time in therapeutic treatment range: a RE-LY genomics substudy

scientific article published on 4 August 2016

Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis

scientific article

Genetic variants associated with angiotensin-converting enzyme inhibitor-induced cough: a genome-wide association study in a Swedish population

scientific article published on 13 January 2017

Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population

scientific article published on 3 May 2016

Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study

scientific article published on 05 June 2013

Genome-Wide Association Study of Metamizole-Induced Agranulocytosis in European Populations

scientific article published on 29 October 2020

Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment

scientific article published on 21 February 2020

Genome-wide association study of warfarin maintenance dose in a Brazilian sample

scientific article

Genotype-guided dosing of vitamin K antagonists

scientific article published on May 2014

Genotyping for CYP2C9 and VKORC1 alleles by a novel point of care assay with HyBeacon® probes

scientific article published on 29 July 2011

Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process

scientific article

Induction of CYP2D6 in pregnancy*

scientific article published on 01 October 1997

Influence of APOE Gene Polymorphism on Interindividual and Interethnic Warfarin Dosage Requirement: A Systematic Review and Meta-Analysis

scientific article published on 6 April 2016

Influence of adenosine triphosphate and ABCB1 (MDR1) genotype on the P-glycoprotein-dependent transfer of saquinavir in the dually perfused human placenta

scientific article published in January 2008

Integration of genetic, clinical, and INR data to refine warfarin dosing

scientific article

Lamotrigine and toxic epidermal necrolysis

scientific article published on 01 October 1996

MTHFR, TYMS and SLCO1B1 polymorphisms and adverse liver effects of methotrexate in rheumatoid arthritis

scientific article published on 06 February 2020

Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long-term follow-up of predictors, surveillance, and outcome in clinical practice

scientific article published on 22 April 2019

Narcolepsy risk loci are enriched in immune cells and suggest autoimmune modulation of the T cell receptor repertoire

Novel regulatory variant detected on the VKORC1 haplotype that is associated with warfarin dose

scientific article published on 5 February 2016

Oral anticoagulation: a critique of recent advances and controversies

scientific article

Pandemrix-induced narcolepsy is associated with genes related to immunity and neuronal survival

article

Patients benefit from genetics-guided coumarin anticoagulant therapy

scientific article

Pharmacogenetic analysis can predict adverse effects of statins

scientific article published on May 7, 2013

Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy

scientific article published on 21 December 2011

Pharmacogenetics of warfarin: current status and future challenges

scientific article published on 19 September 2006

Pharmacogenetics-based warfarin dosing in children

scientific article

Pharmacogenomics and personalized medicine: the plunge into next-generation sequencing

scientific article published on 28 December 2011

Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencing

scientific article published on 26 June 2019

Phenotype standardization for statin-induced myotoxicity

scientific article

Phenotype standardization of angioedema in the head and neck region caused by agents acting on the angiotensin system.

scientific article

Placental transfer of quetiapine in relation to P-glycoprotein activity

Point: use of pharmacogenetics in guiding treatment with warfarin

scientific article published on 30 January 2009

Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer

scientific article published on 01 June 1999

Polymorphisms of NAT2 in relation to sulphasalazine-induced agranulocytosis

scientific article published on 01 February 2000

Possible fluconazole-fentanyl interaction-a case report

scientific article published on 21 April 2006

Practical recommendations for pharmacogenomics-based prescription: 2010 ESF-UB Conference on Pharmacogenetics and Pharmacogenomics

scientific article

Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer

scientific article

Prediction of warfarin dose: why, when and how?

scientific article published on March 2012

Prostate cancer associated with CYP17 genotype

scientific article published on 01 October 1999

Quality of life in patients with venous thromboembolism and atrial fibrillation treated with coumarin anticoagulants

scientific article published on 25 April 2015

Rapid single-nucleotide polymorphism detection of cytochrome P450 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genes for the warfarin dose adjustment by the SMart-amplification process version 2.

scientific article published on 30 January 2009

SWEDEGENE-a Swedish nation-wide DNA sample collection for pharmacogenomic studies of serious adverse drug reactions

scientific article published on 17 January 2020

Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity Reactions

scientific article published on 03 July 2019

Sulfasalazine-induced agranulocytosis is associated with the human leukocyte antigen locus

scientific article published on August 2017

The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update.

scientific article

The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy.

scientific article

The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysis

scientific article published on 08 April 2014

The largest prospective warfarin-treated cohort supports genetic forecasting

scientific article published on 23 June 2008

Warfarin dose prediction in children using pharmacogenetics information

scientific article published on 18 July 2012

Warfarin dose prediction in children using pharmacometric bridging--comparison with published pharmacogenetic dosing algorithms

scientific article published on 11 January 2013

Warfarin dose related to apolipoprotein E (APOE) genotype

scientific article published on 11 June 2005

Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups

scientific article

Warfarin pharmacogenetics: it matters if you're black or white

scientific article published in October 2014

Warfarin-noscapine interaction: a series of four case reports

scientific article

[Preventive work can reduce drug side effects]

miR-133a regulates vitamin K 2,3-epoxide reductase complex subunit 1 (VKORC1), a key protein in the vitamin K cycle

scientific article published on January 2012

Paulina is supported by:

About Paulina

Help